A study by Tu et al. showed that FH535, an inhibitor of the Wnt signaling pathway, can inhibit CRC proliferation by downregulating β-catenin, thereby suppressing the Wnt/β-catenin pathway and affecting CCNA2, a downstream proliferation-related gene69. The gene discussed is CCNA2; the disease is colorectal carcinoma.